Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA repair and recombination protein RAD54-like 2 (RAD54L2), also known as Androgen receptor-interacting protein 4 (ARIP4), is a member of the SNF2 family of DNA-dependent ATPases (UniProt Q9Y4L1). It functions primarily as a transcriptional co-regulator that interacts with the androgen receptor (AR) to modulate its transactivation activity in a DNA-dependent manner (PMID: 11470777). Beyond its role in hormone signaling, RAD54L2 is involved in essential cellular processes including chromatin remodeling and DNA repair, specifically through the homologous recombination pathway (PMID: 21854834). In clinical contexts, RAD54L2 is frequently associated with the progression of prostate cancer, where its overexpression can enhance AR-driven tumor growth and contribute to therapy resistance (NCBI Gene: 10321). Targeting RAD54L2 mRNA via antisense oligonucleotides or RNA interference represents a potential therapeutic strategy to downregulate the protein and inhibit AR-mediated signaling in advanced malignancies. While there are currently no FDA-approved drugs specifically targeting RAD54L2, its ATPase domain and its interaction interface with nuclear receptors are considered high-priority areas for pharmacological development in oncology.
Modulation of androgen receptor-mediated transcription and inhibition of DNA-dependent ATPase activity to disrupt oncogenic signaling and DNA repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA repair and recombination protein RAD54-like 2 (RAD54L2).